Barbara T. Grunwald

Barbara T. Grunwald

Ismaninger Str. 22
Munich, BY 81675, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Pancreatic cancer.

Pancreatic cancer.

Journal: Nature reviews. Disease primers

Published: March 27, 2026

Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery.

Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery.

Journal: Clinics and research in hepatology and gastroenterology

Published: February 11, 2026

Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 11, 2026

Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancer.

Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancer.

Journal: The journal of pathology. Clinical research

Published: January 08, 2026

Tumour tissue: heterogeneous, but not disordered.

Tumour tissue: heterogeneous, but not disordered.

Journal: Nature reviews. Cancer

Published: July 14, 2025

Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer.

Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer.

Journal: BJU international

Published: January 13, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Journal: Nature communications

Published: November 20, 2024

Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.

Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.

Journal: Nature communications

Published: June 09, 2024

Transcription factor switching drives subtype-specific pancreatic cancer.

Transcription factor switching drives subtype-specific pancreatic cancer.

Journal: Nature genetics

Published: February 17, 2024

Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer.

Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer.

Journal: Nature communications

Published: December 14, 2023

Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.

Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.

Journal: Cell reports

Published: October 26, 2023

Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.

Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: October 06, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026